ARCHIVES

NCI Predicts 42 Percent Increase In Number of Senior Survivors

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

March 8, 2002

The New NCI: Structure, Procedures, Advisory Boards To Change, Klausner Says

September 15, 1995

NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups.

January 12, 2007

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

DRCCA Board Oks Noncompetitive Contract Concepts

November 11, 1983

Flat Centers Budget Irks House Subcommittee; Porter Repeats Call For Funding Bypass Budget

March 23, 1990